000 01539 a2200409 4500
005 20250517001248.0
264 0 _c20160108
008 201601s 0 0 eng d
022 _a1932-6203
024 7 _a10.1371/journal.pone.0111412
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCalik, Michael W
245 0 0 _aCannabinoid type 1 and type 2 receptor antagonists prevent attenuation of serotonin-induced reflex apneas by dronabinol in Sprague-Dawley rats.
_h[electronic resource]
260 _bPloS one
_c2014
300 _ae111412 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAnimals
650 0 4 _aCannabinoid Receptor Agonists
_xchemistry
650 0 4 _aDronabinol
_xchemistry
650 0 4 _aElectromyography
650 0 4 _aFemoral Vein
_xpathology
650 0 4 _aIndoles
_xchemistry
650 0 4 _aMale
650 0 4 _aNodose Ganglion
_xdrug effects
650 0 4 _aPiperidines
_xchemistry
650 0 4 _aPyrazoles
_xchemistry
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aReceptor, Cannabinoid, CB1
_xantagonists & inhibitors
650 0 4 _aReceptor, Cannabinoid, CB2
_xantagonists & inhibitors
650 0 4 _aSerotonin
_xadministration & dosage
650 0 4 _aSleep Apnea, Obstructive
_xchemically induced
650 0 4 _aTreatment Outcome
700 1 _aCarley, David W
773 0 _tPloS one
_gvol. 9
_gno. 10
_gp. e111412
856 4 0 _uhttps://doi.org/10.1371/journal.pone.0111412
_zAvailable from publisher's website
999 _c24310955
_d24310955